Dr. Abdulkadir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Wp 230 Dept Pathology
Birmingham, AL 35249
Education & Training
Ahmadu Bello UniversityClass of 1990
Certifications & Licensure
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 59 citationsPim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cellsJie Wang, Philip D. Anderson, Weifeng Luo, David Gius, Meejeon Roh
Oncogene. 2012-04-05 - 57 citationsPim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activityJongchan Kim, Meejeon Roh, Sarki A. Abdulkadir
BMC Cancer. 2010-06-01 - 106 citationsPim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaJie Wang, Jongchan Kim, Meejeon Roh, Omar E. Franco, Simon W. Hayward
Oncogene. 2010-04-29
Journal Articles
- Bmi1 Marks Distinct Castration-Resistant Luminal Progenitor Cells Competent for Prostate Regeneration and Tumour InitiationMohamed M Desouki, Sarki A Abdulkadir, Nature
Press Mentions
2020 Urology Care Foundation Research Scholar Awardees AnnouncedFebruary 11th, 2020
Rare Bacteria Boosts Immunotherapy in Prostate CancerJune 7th, 2018
Inviting Pharma to the DanceMay 10th, 2018- Join now to see all
Grant Support
- Modeling Prostate TumorigenesisNational Cancer Institute2008–2012
- Role Of Oncogenic Kinase PIM-1 In Prostate CancerNational Cancer Institute2007–2011
- Modulation Of Androgen Signaling In Prostate CancerNational Cancer Institute2005–2007
- Modeling Prostate Cancer By Conditional Gene TargetingNational Cancer Institute2005–2006
- Modulation Of Androgen Signaling In Prostate CancerNational Cancer Institute2004
- Role Of Transcription Factor EGR1 In Prostate CancerNational Cancer Institute2003–2004
- Modeling Prostate Cancer By Conditional Gene TargetingNational Cancer Institute2002–2004
- Role Of Transcription Factor Egrl In Prostate CancerNational Cancer Institute2000–2002
- Role Of Transcription Factor Egrl In Prostate CancerNational Cancer Institute2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
